Subscribe
usandind
US President Barack Obama with Indian Prime Minister Manmohan Singh. Official White House Photo by Pete Souza
30 September 2013Patents

India urged to improve its drugs patent policy

India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Patents
‘We created law’: G1/24 and the creation of the ‘diamond standard’
1 July 2025

Editor's picks

Patents
‘We created law’: G1/24 and the creation of the ‘diamond standard’
1 July 2025
AI
What is an ‘AI training declaration’ and who might need one?
20 June 2025
Future of IP
‘Sad beige’ lawsuit shows how hard it is for influencers to stand out
20 June 2025
Trademarks
Creative licence: Inside the LEGO Group’s Asia playbook
16 June 2025
Copyright
‘Cynical and bewildering’: UK omits copyright protections in Data Bill
13 June 2025
Patents
Vidal: Stewart’s ruling steers IPR process ‘dangerously off course’
11 June 2025

More articles

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Tech litigators join Hogan Lovells’ Paris practice from A&O Shearman
How in-house patent pros are ‘enablers of innovation’
Smart IP for startups: how to avoid the common traps
Defending the realm: How a key MoD supplier crafts its IP strategy
How IP firms can champion LGBTQ+ staff beyond Pride 2025
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
AI patent trends signal tomorrow’s technologies